IP Library › Granted Patent US 9,334,464
Granted Patent B2
US 9,334,464 · App. 14/361,389 · Granted May 10, 2016

Microcapsules and uses thereof

Inventors: Damien Berthier (Geneva 8, CH); Andreas Herrmann (Geneva 8, CH); Nicolas Paret (Geneva 8, CH); Lahoussine Ouali (Geneva 8, CH)
Assignee: Firmenich SA
C11B9/0019B01J13/06B01J13/16C11D3/505
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,334,464
App. No.
14/361,389
Granted
May 10, 2016
Kind
B2
Abstract

The present invention relates to core-shell microcapsules comprising photolabile 2-oxoacetate pro-fragrance molecules capable of liberating an active molecule such as, for example, an aldehyde or ketone upon exposure to light. The present invention concerns also the use of said microcapsules in perfumery as well as the perfuming compositions or perfumed articles comprising the invention's microcapsules to provide a prolonged release of fragrant aldehydes and/or ketones.

Claims (26)

1. A core-shell microcapsule comprising:

a) a core of an oily phase containing at least one photolabile pro-fragrance ingredient which is a 2-oxoacetate derivative of formula

wherein,

R 1 represents a linear, branched or cyclic, saturated or unsaturated C 1 -C 16 hydrocarbon group, optionally substituted with one or two methoxy groups, and R 2 is a CH(R′)(R″) group derived from the corresponding C 6-20 perfuming aldehyde of formula (R″)CHO or C 6-20 perfuming ketone of formula (R′)(R″)C═O; and

b) a shell surrounding said core and formed by interfacial polymerisation or by a polymerisation induced phase separation process;

wherein the photolabile pro-fragrance ingredient releases a fragrant aldehyde or ketone when exposed to light by transforming the OR 2 moiety into a perfuming aldehyde (R″)CHO or ketone (R′)(R″)C═O, with simultaneous formation of a R 1 COOH or R 1 CHO residue.

2. A microcapsule according to claim 1 , comprising at least one pro-fragrance ingredient of formula (I) wherein R 1 represents a linear, branched or cyclic C 1 -C 10 hydrocarbon group.

3. A microcapsule according to claim 1 , comprising at least one pro-fragrance ingredient of formula (I) wherein R 1 represents a methyl, ethyl, tert-butyl, isopropyl, cyclopentyl or cyclohexyl group or a phenyl group optionally substituted with one or two methoxy groups.

4. A microcapsule according to claim 1 , comprising at least one pro-fragrance ingredient of formula (I) wherein R 2 is derived from an aldehyde selected from the group consisting of benzaldehyde, 1,3-benzodioxol-5-carboxaldehyde, 3-(1,3-benzodioxol-5-yl)-2-methylpropanal, 3-(4-tert-butyl-1-cyclohexen-1-yl)propanal, 2,4-decadienal, 2-decenal, 4-decenal, 8-decenal, 9-decenal, 3-(6,6-dimethyl-bicyclo[3.1.1]hept-2-en-2-yl)propanal, 2,4-dimethyl-3-cyclohexene-1-carbaldehyde, 3,5-dimethyl-3-cyclohexene-1-carbaldehyde, 1-(3,3-dimethyl-1-cyclohexyl)-1-ethanone, 5,9-dimethyl-4,8-decadienal, 3-(3,3- and 1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal, 2,6-dimethyl-5-heptenal, 3,7-dimethyl-2,6-octadienal, 3,7-dimethyloctanal, 3,7-dimethyl-6-octenal, (3,7-dimethyl-6-octenyl)acetaldehyde, 3-dodecenal, 4-dodecenal, 3-ethoxy-4-hydroxybenzaldehyde, 4-ethyl benzaldehyde, 3-(2 and 4-ethylphenyl)-2,2-dimethylpropanal, 2-furancarbaldehyde, 2,4-heptadienal, 3,5,5,6,7,8,8-heptamethyl-5,6,7,8-tetrahydronaphthalene-2-carbaldehyde, 4-heptenal, 2-hexenal, 3-hexenal, 2-hexyl-3-phenyl-2-propenal, 2-hydroxybenzaldehyde, 7-hydroxy-3,7-dimethyloctanal, 4-hydroxy-3-methoxybenzaldehyde, 4- and 3-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carbaldehyde, 4-isopropylbenzaldehyde, 8-isopropyl-6-methyl-bicyclo[2.2.2]oct-5-ene-2-carbaldehyde, 3-(4-isopropylphenyl)-2-methylpropanal, 2-(4-isopropylphenyl)propanal, 2- and 4-methoxybenzaldehyde, 6-methoxy-2,6-dimethylheptanal, 3-(2-methoxyphenyl)acrylaldehyde, 8(9)-methoxy-tricyclo[5.2.1,0.(2,6)]decane-3(4)-carbaldehyde, 4-methylbenzaldehyde, 3-(4-methylcyclohex-3-en-1-yl)butanal, 2-(4-methylenecyclohexyl)propanal, 1-methyl-4-(4-methyl-3-pentenyl)-3-cyclohexen-1-carbaldehyde, 3-(4-methyl-3-pentenyl)-3-cyclohexene-1-carbaldehyde, 4-(4-methyl-3-pentenyl)-3-cyclohexene-1-carbaldehyde, (4-methylphenoxy)acetaldehyde, (4-methylphenyl)acetaldehyde, 3-methyl-5-phenylpentanal, 2-(1-methylpropyl)-1-cyclohexanone, 2-methyl-4-(2′,2′,3′-trimethyl-3′-cyclopentenyl)-4-pentenal, 2,4-nonadienal, 2,6-nonadienal, 2-nonenal, 3-nonenal, 6-nonenal, 8-nonenal, 2-octenal, 2-pentyl-3-phenyl-2-propenal, phenoxyacetaldehyde, 2-phenylacetaldehyde, 3-phenylbutanal, 3-phenylpropanal, 2-phenylpropanal, 3-phenyl-2-propenal, 4-(prop-1-en-2-yl)cyclohex-1-enecarbaldehyde, 3-(4-tert-butylphenyl)-2-methylpropanal, 3-(4-tert-butylphenyl)propanal, tricyclo[5.2.1,0(2,6)]decane-4-carbaldehyde, exo-tricyclo[5.2.1,0(2,6)]decane-8exo-carbaldehyde, 2,6,6-trimethyl-bicyclo[3.1.1]heptane-3-carbaldehyde, 2,4,6- and 3,5,6-trimethyl-3-cyclohexene-1-carbaldehyde, 2,2,3-trimethyl-3-cyclopentene-1-acetaldehyde, 2,6,10-trimethyl-2,6,9,11-dodecatetraenal, 2,5,6-trimethyl-4-heptenal, 3,5,5-trimethylhexanal, 2,6,10-trimethyl-9-undecenal, 2-undecenal, 10-undecenal or 9-undecenal and their mixtures, an aldehyde of formula (R″)CHO wherein R″ is a linear or α-branched alkyl group of C 6 to C 15 , and their mixtures.

5. A microcapsule according to claim 1 , comprising at least one pro-fragrance ingredient of formula (I) wherein R 2 is derived from a ketone selected from the group consisting of a damascenone, a damascene, a ionone or methyl ionone, irone, macrocyclic ketone such as, for example, cyclopentadecanone or 3-methyl-4-cyclopentadecen-1-one and 3-methyl-5-cyclopentadecen-1-one or 3-methyl-1-cyclopentadecanone, 1-(2-aminophenyl)-1-ethanone, 1-(3,3-dimethyl-1-cyclohexen-1-yl)-4-penten-1-one, 1-(5,5-dimethyl-1-cyclohexen-1-yl)-4-penten-1-one, 1-(3,3-dimethyl-1-cyclohexyl)-1-ethanone, 2,5-dimethyl-2-octene-6-one, 4,7-dimethyl-6-octene-3-one, (3,7-dimethyl-6-octenyloxy)acetaldehyde, 1-(2,4-dimethylphenyl)-1-ethanone, 4-(1,1-dimethylpropyl)-1-cyclohexanone, 2,4-di-tert-butyl-1-cyclohexanone, ethyl 4-oxopentanoate, 1-(4-ethylphenyl)-1-ethanone, 1-(3,5,5,6,8,8-hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone, 2-hexyl-1-cyclopentanone, 2-hydroxy-3-methyl-2-cyclopenten-1-one, 4-(4-hydroxy-1-phenyl)-2-butanone, 1-(2- and 4-hydroxyphenyl)-1-ethanone, 2-isopropyl-5-methylcyclohexanone, 4-isopropyl-2-cyclohexen-1-one, 1-(5-isopropyl-2-methylcyclohex-1- or 2-en-1-yl)propanone, 1-(4-isopropyl-1-phenyl)-1-ethanone, 2-(2-mercaptopropan-2-yl)-5-methylcyclohexanone, 1-(4-methoxyphenyl)-1-ethanone, 7-methyl-2H,4H-1,5-benzodioxepin-3-one, 5-methyl-3-heptanone, 6-methyl-5-hepten-2-one, methyl 3-oxo-2-pentyl-1-cyclopentaneacetate, 1-(4-methylphenyl)-1-ethanone, 5-methyl-2-(propan-2-ylidene)cyclohexanone, 5-methyl-2-(prop-1-en-2-yl)cyclohexanone, 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-enone, 5-methyl-exo-tricyclo[6.2.1,0(2,7)]undecan-4-one, 3-methyl-4-(1,2,2-trimethylpropyl)-4-penten-2-one, 2-naphthalenyl-1-ethanone, 1-(octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)-1-ethanone, 3,4,5,6,6-pentamethyl-3-hepten-2-one, 2-pentyl-1-cyclopentanone, 4-phenyl-2-butanone, 1-phenyl-1-ethanone, 2- and 4-tert-butyl-1-cyclohexanone, 1-(4-tert-butylphenyl)-1-ethanone), 3,5,6,6-tetramethyl-4-methyleneheptan-2-one, 2,4,4,7-tetramethyl-6-octen-3-one, 1,7,7-trimethyl-bicyclo[2.2.1]heptan-2-one, 2,6,6-trimethyl-1-cycloheptanone, 2,6,6-trimethyl-2-cyclohexene-1,4-dione, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-butanone, 1-(2,4,4-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one, 1-(3,5,6-trimethyl-3-cyclohexen-1-yl)-1-ethanone, 2,2,5-trimethyl-5-pentyl-1-cyclopentanone or a C 6-15 ketone of formula (R′)(R″)C=o wherein R′ and R″ are linear alkyl groups, and their mixtures.

6. A microcapsule according to claim 1 , comprising at least one pro-fragrance ingredient of formula (I) selected from the group consisting of 3-(4-tert-butyl-1-cyclohexen-1-yl)propyl 2-oxo-2-phenylacetate, 3-(4-tert-butylphenyl)-2-methylpropyl 2-cyclohexyl-2-oxoacetate, 3-(4-(tert-butyl)phenyl)-2-methylpropyl 2-oxo-2-phenylacetate, decyl 2-cyclohexyl-2-oxoacetate, decyl 2-oxo-2-phenylacetate, (2,4-dimethyl-3-cyclohexen-1-yl)methyl 2-cyclohexyl-2-oxoacetate, (2,4-dimethyl-3-cyclohexen-1-yl)methyl 2-oxo-2-phenylacetate, 1-(3,3- and 5,5-dimethyl-1-cyclohexen-1-yl)-4-pentenyl 2-oxo2-phenylacetate, 3-(3,3- and 1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)propyl 2-oxo-2-phenylacetate, 2,6-dimethyl-5-heptenyl 2-oxo-2-phenylacetate, 3,7-dimethyl-2,6-octadienyl 2-cyclohexyl-2-oxoacetate, 3,7-dimethyl-2,6-octadienyl 2-(4-methylcyclohexyl)-2-oxoacetate, 3,7-dimethyl-2,6-octadienyl 3-methyl-2-oxopentanoate, 3,7-dimethyl-2,6-octadienyl 2-oxo-2-phenylacetate, 3,7-dimethyl-2,6-octadienyl 2-oxopropanoate, 3,7-dimethyl-6-octenyl 2-(4-acetylphenyl)-2-oxoacetate, 3,7-dimethyl-6-octenyl(bicyclo[2.2.1]hept-2exo-yl)oxoacetate, 3,7-dimethyl-6-octenyl 2-cyclohexyl-2-oxoacetate, 3,7-dimethyl-6-octenyl 2-cyclopentyl-2-oxoacetate, 3,7-dimethyl-6-octenyl 2-(4-methylcyclohexyl)-2-oxoacetate, 3,7-dimethyl-6-octenyl[4-(2-methyl-1,3-dioxolan-2-yl)phenyl]oxoacetate, 3,7-dimethyl-6-octenyl 3-methyl-2-oxopentadecanoate, 3,7-dimethyl-6-octenyl 3-methyl-2-oxopentanoate, 3,7-dimethyl-6-octenyl 2-oxobutanoate, 3,7-dimethyl-6-octenyl 2-oxohexadecanoate, 3,7-dimethyl-6-octenyl 2-oxopentanoate, 3,7-dimethyl-6-octenyl 2-oxo-2-phenylacetate, 3,7-dimethyl-6-octenyl 2-oxopropanoate, 4-(1,1-dimethylpropyl)-1-cyclohexyl 2-cyclohexyl-2-oxoacetate, 4-dodecenyl 2-oxo-2-phenylacetate, 3,5,5,6,7,8,8-heptamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)methyl 2-oxo-2-phenylacetate, 1-(3,5,5,6,8,8-hexamethyl-5,6,7,8-tetrahydro-2-naphthalenyl)ethyl 2-oxo-2-phenylacetate, 3-hexenyl 2-oxo-2-phenylacetate, 3-hexenyl 2-oxopropanoate, 7-hydroxy-3,7-dimethyloctyl 2-oxo2-phenylacetate, [4- and 3-(4-hydroxy-4-methylpentyl)-3-cyclohexen-1-yl]methyl 2-oxo-2-phenylacetate, 2-isopropyl-5-methylcyclohexyl 2-cyclohexyl-2-oxoacetate, 2-isopropyl-5-methylcyclohexyl 2-oxo-2-phenylacetate, 4-methoxybenzyl 2-cyclohexyl-2-oxoacetate, [4- and 3-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl]methyl 2-oxo-2-phenylacetate, 3-methyl-5-phenylpentyl 2-oxo-2-phenylacetate, 2-methyl-4-(2′,2′,3′-trimethyl-3′-cyclopenten-1′-yl)-4-pentenyl 2-oxo-2-phenylacetate, 2,6-nonadienyl 2-oxo-2-phenylacetate, 3-nonenyl 2-oxo-2-phenylacetate, 2-pentyl-1-cyclopentyl 2-cyclohexyl-2-oxoacetate, 4-phenylbutan-2-yl 2-oxo-2-phenylacetate, 2-phenylethyl 2-oxo-2-phenylacetate, 2-phenylethyl 2-oxopropanoate, 3,5,6,6-tetramethyl-4-methyleneheptan-2-yl 2-oxo-2-phenylacetate, 4-(2,6,6-trimethyl-2-cyclohexenyl)-3-buten-2-yl 2-oxo-2-phenylacetate, 9-undecenyl 2-oxo-2-phenylacetate or 10-undecenyl 2-oxo-2-phenylacetate.

7. A microcapsule according to claim 1 , wherein said microcapsules has an average size of 1 to 200 micrometers.

8. A microcapsule according to claim 1 , wherein said microcapsules has a nominal shell to core mass ratio lower than 20%.

9. A microcapsule slurry consisting of a water-based dispersion or suspension of microcapsules according to claim 1 .

10. A perfuming composition characterized in that it comprises:

a) one or more microcapsules as defined in claim 1 , or a slurry according to claim 9 ;

b) at least one ingredient selected from the group consisting of a perfumery carrier and a perfumery base; and

c) optionally at least one perfumery adjuvant.

11. A consumer product, characterized in that it comprises:

a) as perfuming ingredient, a microcapsule as defined in claim 1 , a slurry according to claim 9 , or a perfuming composition according to claim 10 ; and

b) a consumer product base.

12. A method for intensifying or prolonging the diffusion effect of the characteristic odor of a fragrant aldehyde and/or ketone on a surface, characterized in that said surface is treated with

a) a microcapsule as defined in any one of claims 1 to 8 or a slurry according to claim 9 ;

b) a perfuming composition according to claim 10 ; or

c) a consumer product according to claim 11 ,

under conditions which are susceptible of allowing the release of the fragrant aldehyde and/or ketone.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2014
From: BERTHIER, DAMIEN; HERRMANN, ANDREAS; PARET, NICHOLAS; OUALI, LAHOUSSINE
To: FIRMENICH SA
Reel/Frame 032997/0427 →
Priority Claims (1)
EP 11191101 · Nov 29, 2011 · regional
Continuity (1)
Related Publication 20140323376A1 · Oct 30, 2014